Janux Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Janux Therapeutics using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-0.39 | $-0.61 | 36.1 % |
| Q2 | 2025-08-07 | $-0.55 | $-0.47 | -17.0 % |
| Q1 | 2025-05-08 | $-0.38 | $-0.39 | 2.56 % |
| Q4 | 2025-02-27 | $-0.36 | $-0.45 | 20.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $10.00M | $4.97M | 101.3 % |
| Q2 | 2025-08-07 | $0 | $272.73K | -100.0 % |
| Q1 | 2025-05-08 | $0 | $650.00K | -100.0 % |
| Q4 | 2025-02-27 | $0 | $490.00K | -100.0 % |
Janux Therapeutics (JANX) is scheduled to report earnings on February 26, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.
The Actual EPS was $-0.39, which beat the estimate of $-0.61.
The Actual Revenue was $10M, which beat the estimate of $5M.
Browse earnings estimates, EPS, and revenue on all stocks.